Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 690835, 20 pages
http://dx.doi.org/10.1155/2013/690835
Review Article

Understanding the Dengue Viruses and Progress towards Their Control

1“Pedro Kouri” Tropical Medicine Institute, WHO/PAHO Collaborating Centre for the Study of Dengue and Its Vector, Autopista Novia del Mediodía, Km 6 1/2, La Lisa, P.O. Box 601, Marianao 13, 11300 Havana, Cuba
2UMR190, Emergence des Pathologies Virales, Aix-Marseille Universite, Institut de Recherche pour le Développement, Ecole des Hautes Etudes en Santé Publique, Unité des Virus Emergents, Faculté de Médecine de Marseille, 27 Boulevard Jean Moulin, 13005 Marseille cedex 05, France
3CEH Wallingford, Maclean Building, Benson Lane, Crowmarsh Gifford, Oxfordshire OX10 8BB, UK

Received 13 March 2013; Accepted 8 May 2013

Academic Editor: Vittorio Sambri

Copyright © 2013 Rosmari Rodriguez-Roche and Ernest A. Gould. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. P. Pinheiro and S. J. Corber, “Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas,” World Health Statistics Quarterly, vol. 50, no. 3-4, pp. 161–169, 1997. View at Google Scholar · View at Scopus
  2. D. J. Gubler, “The global emergence/resurgence of arboviral diseases as public health problems,” Archives of Medical Research, vol. 33, no. 4, pp. 330–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Halstead, “Dengue,” The Lancet, vol. 370, no. 9599, pp. 1644–1652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. De A. Zanotto, E. A. Gould, G. F. Gao, P. H. Harvey, and E. C. Holmes, “Population dynamics of flaviviruses revealed by molecular phylogenies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 2, pp. 548–553, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. WHO, Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, WHO, Geneva, Switzerland, 2nd edition, 1997.
  6. L. M. Ling, A. Wilder-Smith, and Y. S. Leo, “Fulminant hepatitis in dengue haemorrhagic fever,” Journal of Clinical Virology, vol. 38, no. 3, pp. 265–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Gulati and A. Maheshwari, “Atypical manifestations of dengue,” Tropical Medicine and International Health, vol. 12, no. 9, pp. 1087–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Kumar, S. Tripathi, J. J. Tambe, V. Arora, A. Srivastava, and V. L. Nag, “Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue,” Journal of the Neurological Sciences, vol. 269, no. 1-2, pp. 41–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Wasay, R. Channa, M. Jumani, G. Shabbir, M. Azeemuddin, and A. Zafar, “Encephalitis and myelitis associated with dengue viral infection. Clinical and neuroimaging features,” Clinical Neurology and Neurosurgery, vol. 110, no. 6, pp. 635–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Solomon, N. M. Dung, D. W. Vaughn et al., “Neurological manifestations of dengue infection,” The Lancet, vol. 355, no. 9209, pp. 1053–1059, 2000. View at Google Scholar · View at Scopus
  11. S. B. Park, S. Y. Ryu, K. B. Jin et al., “Acute colitis associated with dengue fever in a renal transplant recipient,” Transplantation Proceedings, vol. 40, no. 7, pp. 2431–2432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Balmaseda, S. N. Hammond, M. A. Pérez et al., “Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 6, pp. 1059–1062, 2005. View at Google Scholar · View at Scopus
  13. S. Bandyopadhyay, L. C. S. Lum, and A. Kroeger, “Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever,” Tropical Medicine and International Health, vol. 11, no. 8, pp. 1238–1255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. G. Rigau-Pérez, “Severe dengue: the need for new case definitions,” Lancet Infectious Diseases, vol. 6, no. 5, pp. 297–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Deen, E. Harris, B. Wills et al., “The WHO dengue classification and case definitions: time for a reassessment,” The Lancet, vol. 368, no. 9530, pp. 170–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Alexander, A. Balmaseda, I. C. B. Coelho et al., “Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries,” Tropical Medicine and International Health, vol. 16, no. 8, pp. 936–948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. WHO/TDR, Dengue Guidelines for Diagnosis, Treatment, Prevention and Control, WHO Press, Geneva, Switzerland, 2009.
  18. N. A. Akbar, I. Allende, A. Balmaseda et al., “Regarding “Dengue—how best to classify it”,” Clinical Infectious Diseases, vol. 54, no. 12, pp. 1820–1821, 2012, author reply 1821-1822. View at Publisher · View at Google Scholar
  19. A. Srikiatkhachorn, A. L. Rothman, R. V. Gibbons et al., “Dengue-how best to classify it,” Clinical Infectious Diseases, vol. 53, no. 6, pp. 563–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kalayanarooj, “Dengue classification: current WHO vs. the newly suggested classification for better clinical application?” Journal of the Medical Association of Thailand, vol. 94, pp. S74–84, 2011. View at Google Scholar · View at Scopus
  21. S. B. Halstead, “Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition,” The American Journal of Tropical Medicine and Hygiene, vol. 88, no. 2, pp. 212–215, 2013. View at Publisher · View at Google Scholar
  22. J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Ochlerotatus and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” Zoological Journal of the Linnean Society, vol. 153, no. 1, pp. 29–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Aedini (Diptera: Culicidae), based on morphological characters of all life stages,” Zoological Journal of the Linnean Society, vol. 142, no. 3, pp. 289–368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Finlaya and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” Zoological Journal of the Linnean Society, vol. 148, no. 1, pp. 1–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. E. A. Gould, X. de Lamballerie, P. M. D. A. Zanotto, and E. C. Holmes, “Origins, evolution, and vector{plus 45 degree rule}host coadaptations within the Genus Flavivirus,” Advances in Virus Research, vol. 59, pp. 277–314, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. G. K. Strode, Yellow Fever, McGraw-Hill, New York, NY, USA, 1951.
  27. W. J. Tabachnick, “Evolutionary genetics and arthropod-borne diseases. The yellow fever mosquito, Aedes aegypti,” American Journal of Entomology, vol. 37, pp. 14–24, 1991. View at Google Scholar
  28. L. P. Lounibos, “Invasions by insect vectors of human disease,” Annual Review of Entomology, vol. 47, pp. 233–266, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. X. De Lamballerie, E. Leroy, R. N. Charrel, K. Ttsetsarkin, S. Higgs, and E. A. Gould, “Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?” Virology Journal, vol. 5, article 33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Tatem, R. W. Snow, and S. I. Hay, “Mapping the environmental coverage of the INDEPTH demographic surveillance system network in rural Africa,” Tropical Medicine and International Health, vol. 11, no. 8, pp. 1318–1326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. J. Bloom, The Mississippi Valley's Great Yellow Fever Epidemic of 1978, Louisiana State University Press, Baton Rouge, Lo, USA, 1993.
  32. B. Rush, “An account of the bilious remitting fever. As it appeared in philadelphia, in the summer and autumn of the year 1780,” The American Journal of Medicine, vol. 11, no. 5, pp. 546–550, 1951. View at Google Scholar · View at Scopus
  33. S. B. Halstead, “Dengue in the Americas and Southeast Asia: do they differ?” Revista Panamericana de Salud Publica, vol. 20, no. 6, pp. 407–415, 2006. View at Google Scholar · View at Scopus
  34. D. Gubler, “Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem,” in Dengue and Dengue Hemorrhagic Fever, D. Gubler and G. Kuno, Eds., pp. 1–22, CAB International, 1997. View at Google Scholar
  35. D. J. Gubler, “The emergence of dengue/dengue haemorrhagic fever as a global public health problem,” in Factors in the Emergence of Arbovirus Diseases, J. F. Saluzzo and B. Dodet, Eds., pp. 83–92, Elsevier, Paris, France, 1997. View at Google Scholar
  36. D. J. Gubler, “Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century,” Trends in Microbiology, vol. 10, no. 2, pp. 100–103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. D. J. Gubler, “Dengue/dengue haemorrhagic fever: history and current status,” Novartis Foundation Symposium, vol. 277, pp. 3–16, 2006, discussion 16–22, 71–13, 251–253. View at Google Scholar · View at Scopus
  38. S. B. Halstead, “Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir,” Revista Cubana de Medicina Tropical, vol. 54, no. 3, pp. 171–179, 2002. View at Google Scholar · View at Scopus
  39. S. B. Halstead, “Dengue virus-mosquito interactions,” Annual Review of Entomology, vol. 53, pp. 273–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. E. Blanton, L. K. Silva, V. G. Morato et al., “Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population,” European Journal of Human Genetics, vol. 16, no. 6, pp. 762–765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. B. D. L. C. Sierra, G. Kourí, and M. G. Guzmán, “Race: a risk factor for dengue hemorrhagic fever,” Archives of Virology, vol. 152, no. 3, pp. 533–542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. G. Guzman and G. Kouri, “Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges,” Journal of Clinical Virology, vol. 27, no. 1, pp. 1–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Singh, T. Kiedrzynski, C. Lepers, and E. K. Benyon, “Dengue in the Pacific—an update of the current situation,” Pacific Health Dialog, vol. 12, no. 2, pp. 111–119, 2005. View at Google Scholar · View at Scopus
  44. A. Wilder-Smith and D. J. Gubler, “Geographic expansion of dengue: the impact of international travel,” Medical Clinics of North America, vol. 92, no. 6, pp. 1377–1390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Franco, N. A. Hynes, N. Bouri, and D. A. Henderson, “The dengue threat to the United States,” Biosecurity and Bioterrorism, vol. 8, no. 3, pp. 273–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. E. A. Gould, P. Gallian, X. De Lamballerie, and R. N. Charrel, “First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!,” Clinical Microbiology and Infection, vol. 16, no. 12, pp. 1702–1704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. I. C. Kurolt, L. Betica-Radic, O. Dakovic-Rode et al., “Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia,” Clinical Microbiology and Infection, vol. 19, no. 3, pp. 163–165, 2013. View at Google Scholar
  48. M. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 102, no. 6, pp. 522–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. M. G. Guzman, S. Vazquez, E. Martinez et al., “Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas,” Boletin de la Oficina Sanitaria Panamericana, vol. 121, no. 2, pp. 102–110, 1996. View at Google Scholar · View at Scopus
  50. M. G. Guzmán, D. Rosario, M. Muné, M. Alvarez, R. Rodríguez, and G. Kourí, “Genetic relatedness of the dengue 3 virus isolated in the outbreak of dengue hemorrhagic fever in Nicaragua, 1994,” Revista Cubana de Medicina Tropical, vol. 48, no. 2, pp. 114–117, 1996. View at Google Scholar · View at Scopus
  51. R. Rico-Hesse, “Microevolution and virulence of dengue viruses,” Advances in Virus Research, vol. 59, pp. 315–341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. G. Teixeira, M. C. N. Costa, G. Coelho, and M. L. Barreto, “Recent shift in age pattern of dengue hemorrhagic fever, Brazil,” Emerging Infectious Diseases, vol. 14, no. 10, p. 1663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. L. P. Cavalcanti, D. Vilar, R. Souza-Santos, and M. G. Teixeira, “Change in age pattern of persons with dengue, Northeastern Brazil,” Emerging Infectious Diseases, vol. 17, no. 1, pp. 132–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Q. Benedict, R. S. Levine, W. A. Hawley, and L. P. Lounibos, “Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus,” Vector-Borne and Zoonotic Diseases, vol. 7, no. 1, pp. 76–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. R. N. Charrel, X. De Lamballerie, and D. Raoult, “Chikungunya outbreaks—the globalization of vectorborne diseases,” The New England Journal of Medicine, vol. 356, no. 8, pp. 769–771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Sousa, M. Clairouin, G. Seixas et al., “Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report,” Eurosurveillance, vol. 17, no. 49, article 3, 2012. View at Google Scholar
  57. C. Caminade, J. M. Medlock, E. Ducheyne et al., “Suitability of European climate for the Asian tiger mosquito Aedes albopictus: recent trends and future scenarios,” Journal of the Royal Society Interface, vol. 9, no. 75, pp. 2708–2717, 2012. View at Publisher · View at Google Scholar
  58. W. F. Wright and B. S. Pritt, “Update: the diagnosis and management of dengue virus infection in North America,” Diagnostic Microbiology and Infectious Disease, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Wu, Q. Liu, L. Lu, J. Wang, X. Song, and D. Ren, “Distribution of Aedes albopictus (Diptera: Culicidae) in northwestern China,” Vector-Borne and Zoonotic Diseases, vol. 11, no. 8, pp. 1181–1186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. G. Guzmán, “Deciphering dengue: the Cuban experience,” Science, vol. 309, no. 5740, pp. 1495–1497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. G. K. Tan and S. Alonso, “Pathogenesis and prevention of dengue virus infection: state-of-the-art,” Current Opinion in Infectious Diseases, vol. 22, no. 3, pp. 302–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Mathew and A. L. Rothman, “Understanding the contribution of cellular immunity to dengue disease pathogenesis,” Immunological Reviews, vol. 225, no. 1, pp. 300–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” The American Journal of Tropical Medicine and Hygiene, vol. 75, no. 6, pp. 1113–1117, 2006. View at Google Scholar · View at Scopus
  64. M. G. Guzmán, G. Kouri, L. Valdes et al., “Epidemiologic studies on dengue in Santiago de Cuba, 1997,” American Journal of Epidemiology, vol. 152, no. 9, pp. 793–799, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. M. G. Guzman, M. Alvarez, R. Rodriguez et al., “Fatal dengue hemorrhagic fever in Cuba,” International Journal of Infectious Diseases, vol. 3, no. 3, pp. 130–135, 1997. View at Google Scholar
  66. M. G. Guzman, G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier, “Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study,” The American Journal of Tropical Medicine and Hygiene, vol. 42, no. 2, pp. 179–184, 1990. View at Google Scholar · View at Scopus
  67. J. R. Bravo, M. G. Guzmán, and G. P. Kouri, “Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS),” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 81, no. 5, pp. 816–820, 1987. View at Google Scholar · View at Scopus
  68. L. Valdés, M. G. Guzmán, G. Kourí et al., “The epidemiology of dengue and dengue hemorrhagic fever in Santiago de Cuba, 1997,” Revista Panamericana de Salud Publica, vol. 6, no. 1, pp. 16–25, 1999. View at Google Scholar · View at Scopus
  69. N. Sangkawibha, S. Rojanasuphot, and S. Ahandrik, “Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak,” American Journal of Epidemiology, vol. 120, no. 5, pp. 653–669, 1984. View at Google Scholar · View at Scopus
  70. S. B. Halstead, S. Nimmannitya, and M. R. Margiotta, “Dengue d chikungunya virus infection in man in Thailand, 1962–1964. II. Observations on disease in outpatients,” The American Journal of Tropical Medicine and Hygiene, vol. 18, no. 6, pp. 972–983, 1969. View at Google Scholar · View at Scopus
  71. S. B. Halstead, “The pathogenesis of dengue. Molecular epidemiology in infectious disease,” American Journal of Epidemiology, vol. 114, no. 5, pp. 632–648, 1981. View at Google Scholar · View at Scopus
  72. D. M. Morens, “Antibody-dependent enhancement of infection and the pathogenesis of viral disease,” Clinical Infectious Diseases, vol. 19, no. 3, pp. 500–512, 1994. View at Google Scholar · View at Scopus
  73. B. J. Mady, D. V. Erbe, I. Kurane, M. W. Fanger, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcγ receptors,” Journal of Immunology, vol. 147, no. 9, pp. 3139–3144, 1991. View at Google Scholar · View at Scopus
  74. I. Kurane, B. J. Mady, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection,” Reviews in Medical Virology, vol. 1, no. 4, pp. 211–221, 1991. View at Google Scholar · View at Scopus
  75. S. Halstead, Antibody-Dependent Enhancement of Infection: a mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses, Harbor Laboraty Press, Cold Spring Harbor, NY, USA, 1994.
  76. A. B. Sabin and R. Walter Schlesinger, “Production of immunity to dengue with virus modified by propagation in mice1,” Science, vol. 101, no. 2634, pp. 640–642, 1945. View at Google Scholar · View at Scopus
  77. T. Chareonsirisuthigul, S. Kalayanarooj, and S. Ubol, “Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells,” Journal of General Virology, vol. 88, no. 2, pp. 365–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Ubol, T. Chareonsirisuthigul, J. Kasisith, and C. Klungthong, “Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells,” Virology, vol. 376, no. 2, pp. 290–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Cologna, P. M. Armstrong, and R. Rico-Hesse, “Selection for virulent dengue viruses occurs in humans and mosquitoes,” Journal of Virology, vol. 79, no. 2, pp. 853–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. M. G. Guzman, V. Deubel, J. L. Pelegrino et al., “Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic,” The American Journal of Tropical Medicine and Hygiene, vol. 52, no. 3, pp. 241–246, 1995. View at Google Scholar · View at Scopus
  81. T. J. Kochel, D. M. Watts, S. B. Halstead et al., “Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever,” The Lancet, vol. 360, no. 9329, pp. 310–312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. D. M. Watts, K. R. Porter, P. Putvatana et al., “Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever,” The Lancet, vol. 354, no. 9188, pp. 1431–1434, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Rico-Hesse, L. M. Harrison, R. A. Salas et al., “Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas,” Virology, vol. 230, no. 2, pp. 244–251, 1997. View at Publisher · View at Google Scholar · View at Scopus
  84. K. C. Leitmeyer, D. W. Vaughn, D. M. Watts et al., “Dengue virus structural differences that correlate with pathogenesis,” Journal of Virology, vol. 73, no. 6, pp. 4738–4747, 1999. View at Google Scholar · View at Scopus
  85. D. González, O. E. Castro, G. Kourí et al., “Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002,” International Journal of Infectious Diseases, vol. 9, no. 5, pp. 280–285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Limonta, D. González, V. Capó et al., “Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic,” International Journal of Infectious Diseases, vol. 13, no. 2, pp. e77–e78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. M.-S. Lee, K.-P. Hwang, T.-C. Chen, P.-L. Lu, and T.-P. Chen, “Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic,” Journal of Microbiology, Immunology and Infection, vol. 39, no. 2, pp. 121–129, 2006. View at Google Scholar · View at Scopus
  88. B. Sierra, R. Alegre, A. B. Pérez et al., “HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection,” Human Immunology, vol. 68, no. 6, pp. 531–540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. C. LaFleur, J. Granados, G. Vargas-Alarcon et al., “HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever,” Human Immunology, vol. 63, no. 11, pp. 1039–1044, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. H. A. F. Stephens, R. Klaythong, M. Sirikong et al., “HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais,” Tissue Antigens, vol. 60, no. 4, pp. 309–318, 2002. View at Publisher · View at Google Scholar · View at Scopus
  91. M. L. Paradoa Pérez, Y. Trujillo, and P. Basanta, “Association of dengue hemorrhagic fever with the HLA system,” Haematologia, vol. 20, no. 2, pp. 83–87, 1987. View at Google Scholar · View at Scopus
  92. U. C. Chaturvedi, R. Nagar, and R. Shrivastava, “Dengue and dengue haemorrhagic fever: implications of host genetics,” FEMS Immunology and Medical Microbiology, vol. 47, no. 2, pp. 155–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. G. García, B. Sierra, A. B. Pérez et al., “Asymptomatic dengue infection in a cuban population confirms the protective role of the RR variant of the FcγRIIa polymorphism,” The American Journal of Tropical Medicine and Hygiene, vol. 82, no. 6, pp. 1153–1156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Mongkolsapaya, T. Duangchinda, W. Dejnirattisai et al., “T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?” Journal of Immunology, vol. 176, no. 6, pp. 3821–3829, 2006. View at Google Scholar · View at Scopus
  95. K. Clyde, J. L. Kyle, and E. Harris, “Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis,” Journal of Virology, vol. 80, no. 23, pp. 11418–11431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. B. Sierra, A. B. Perez, K. Vogt et al., “Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?” Cellular Immunology, vol. 262, no. 2, pp. 134–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Whitehorn and C. P. Simmons, “The pathogenesis of dengue,” Vaccine, vol. 29, no. 42, pp. 7221–7228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Avirutnan, N. Punyadee, S. Noisakran et al., “Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement,” Journal of Infectious Diseases, vol. 193, no. 8, pp. 1078–1088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. C.-F. Lin, S.-W. Wan, M.-C. Chen et al., “Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model,” Laboratory Investigation, vol. 88, no. 10, pp. 1079–1089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. H.-J. Cheng, C.-F. Lin, H.-Y. Lei et al., “Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies,” Experimental Biology and Medicine, vol. 234, no. 1, pp. 63–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. C.-F. Lin, S.-W. Wan, H.-J. Cheng, H.-Y. Lei, and Y.-S. Lin, “Autoimmune pathogenesis in dengue virus infection,” Viral Immunology, vol. 19, no. 2, pp. 127–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. M. G. Brown, Y. Y. Huang, J. S. Marshall, C. A. King, D. W. Hoskin, and R. Anderson, “Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells,” Journal of Leukocyte Biology, vol. 85, no. 1, pp. 71–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. M. G. Brown, C. A. King, C. Sherren, J. S. Marshall, and R. Anderson, “A dominant role for FcγRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1242–1250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. A. K. I. Falconar, “The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis,” Archives of Virology, vol. 142, no. 5, pp. 897–916, 1997. View at Publisher · View at Google Scholar · View at Scopus
  105. D. T. Tam, T. V. Ngoc, N. T. Tien et al., “Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial,” Clinical Infectious Diseases, vol. 55, no. 9, pp. 1216–1224, 2012. View at Publisher · View at Google Scholar
  106. S.-W. Lin, Y.-C. Chuang, Y.-S. Lin, H.-Y. Lei, H.-S. Liu, and T.-M. Yeh, “Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation,” Journal of Infection, vol. 64, no. 3, pp. 325–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. S. B. Halstead, “Dengue vascular permeability syndrome: what, no T cells?” Clinical Infectious Diseases, vol. 56, no. 6, pp. 900–901, 2013. View at Publisher · View at Google Scholar
  108. D. H. Libraty, P. R. Young, D. Pickering et al., “High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever,” Journal of Infectious Diseases, vol. 186, no. 8, pp. 1165–1168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. H. T. L. Duyen, T. V. Ngoc, D. T. Ha et al., “Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status,” Journal of Infectious Diseases, vol. 203, no. 9, pp. 1292–1300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. V. Tricou, N. N. Minh, J. Farrar, H. T. Tran, and C. P. Simmons, “Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue,” PLoS Neglected Tropical Diseases, vol. 5, no. 9, Article ID e1309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. S. I. de la Cruz-Hernandez, H. Flores-Aguilar, S. Gonzalez-Mateos et al., “Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico,” The American Journal of Tropical Medicine and Hygiene, vol. 88, no. 3, pp. 446–454, 2013. View at Publisher · View at Google Scholar
  112. A. Fox, L. N. M. Hoa, C. P. Simmons et al., “Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam,” PLoS Neglected Tropical Diseases, vol. 5, no. 3, article e967, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. G. P. Kouri, M. G. Guzmán, and J. R. Bravo, “Why dengue haemorrhagic fever in Cuba? 2. An integral analysis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 81, no. 5, pp. 821–823, 1987. View at Google Scholar · View at Scopus
  114. J. L. Kyle and E. Harris, “Global spread and persistence of dengue,” Annual Review of Microbiology, vol. 62, pp. 71–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. P. Mas Lago, “Dengue fever in Cuba in 1977: some laboratory aspects,” PAHO Scientific Publication, vol. 375, pp. 40–43, 1979. View at Google Scholar
  116. P. Mas Lago, R. Palomera, and M. Jacobo, “Dengue: some epidemiologic aspects,” Revista Cubana de Medicina Tropical, vol. 22, no. 6, 1983. View at Google Scholar
  117. N. Cantelar de Francisco, A. Fernández, L. Albert Molina, and E. Pérez Balbis, “Survey of dengue in Cuba. 1978-1979,” Revista Cubana de Medicina Tropical, vol. 33, no. 1, pp. 72–78, 1981. View at Google Scholar · View at Scopus
  118. S. B. Halstead, S. Nimmannitya, and S. N. Cohen, “Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered,” Yale Journal of Biology and Medicine, vol. 42, no. 5, pp. 311–328, 1970. View at Google Scholar · View at Scopus
  119. M. G. Guzmán, G. Kouri, J. Bravo, M. Soler, and E. Martínez, “Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic,” Memorias do Instituto Oswaldo Cruz, vol. 86, no. 3, p. 367, 1991. View at Google Scholar · View at Scopus
  120. G. Kourí, M. G. Guzmán, L. Valdés et al., “Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba,” Emerging Infectious Diseases, vol. 4, no. 1, pp. 89–92, 1998. View at Google Scholar · View at Scopus
  121. M. G. Guzmán, G. Kourí, L. Valdés, J. Bravo, S. Vázquez, and S. B. Halstead, “Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks,” Revista Panamericana de Salud Publica, vol. 11, no. 4, pp. 223–227, 2002. View at Google Scholar · View at Scopus
  122. O. Peláez, M. G. Guzmán, G. Kouri et al., “Dengue 3 epidemic, Havana, 2001,” Emerging Infectious Diseases, vol. 10, no. 4, pp. 719–722, 2004. View at Publisher · View at Google Scholar
  123. M. Álvarez, A. Pavón-Oro, S. Vázquez, L. Morier, Á. M. Álvarez, and M. G. Guzmán, “Viral infection sequences related to dengue fever in dengue 3 epidemics occurred in the City of Havana, 2001-2002,” Revista Cubana de Medicina Tropical, vol. 60, no. 1, pp. 18–23, 2008. View at Google Scholar · View at Scopus
  124. M. Alvarez, A. Pavon-Oro, R. Rodriguez-Roche et al., “Neutralizing antibody response variation against dengue 3 strains,” Journal of Medical Virology, vol. 80, no. 10, pp. 1783–1789, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. R. Rodriguez-Roche, M. Alvarez, E. C. Holmes et al., “Dengue virus type 3, Cuba, 2000–2002,” Emerging Infectious Diseases, vol. 11, no. 5, pp. 773–774, 2005. View at Google Scholar · View at Scopus
  126. R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic,” Archives of Virology, vol. 150, no. 3, pp. 415–425, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. A. B. Sabin, “Research on dengue during World War II,” The American Journal of Tropical Medicine and Hygiene, vol. 1, no. 1, pp. 30–50, 1952. View at Google Scholar · View at Scopus
  128. M. G. Guzman, M. Alvarez, R. Rodriguez-Roche et al., “Neutralizing antibodies after infection with dengue 1 virus,” Emerging Infectious Diseases, vol. 13, no. 2, pp. 282–286, 2007. View at Google Scholar · View at Scopus
  129. M. G. Guzmán, G. Kourí, and S. B. Halstead, “Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?” The Lancet, vol. 355, no. 9218, pp. 1902–1903, 2000. View at Google Scholar · View at Scopus
  130. R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Virus evolution during a severe dengue epidemic in Cuba, 1997,” Virology, vol. 334, no. 2, pp. 154–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  131. J. Mongkolsapaya, W. Dejnirattisai, X.-N. Xu et al., “Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever,” Nature Medicine, vol. 9, no. 7, pp. 921–927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. S. N. Bennett, E. C. Holmes, M. Chirivella et al., “Selection-driven evolution of emergent dengue virus,” Molecular Biology and Evolution, vol. 20, no. 10, pp. 1650–1658, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. C. Klungthong, C. Zhang, M. P. Mammen Jr., S. Ubol, and E. C. Holmes, “The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand,” Virology, vol. 329, no. 1, pp. 168–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  134. H.-L. Chen, S.-R. Lin, H.-F. Liu, C.-C. King, S.-C. Hsieh, and W.-K. Wang, “Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in Southern Taiwan in 2001-2002,” The American Journal of Tropical Medicine and Hygiene, vol. 79, no. 4, pp. 495–504, 2008. View at Google Scholar · View at Scopus
  135. Y. Tang, P. Rodpradit, P. Chinnawirotpisan et al., “Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years,” The American Journal of Tropical Medicine and Hygiene, vol. 83, no. 5, pp. 1156–1165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. R. Zhao, P. Chinnawirotpisan, C. Klungthong, C. Zhang, and R. Putnak, “Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001,” Virus Genes, vol. 41, no. 1, pp. 5–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. R. Rico-Hesse, “Dengue virus evolution and virulence models,” Clinical Infectious Diseases, vol. 44, no. 11, pp. 1462–1466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. A. Steel, D. J. Gubler, and S. N. Bennett, “Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago,” Virology, vol. 405, no. 2, pp. 505–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. R. Rodriguez-Roche, E. Villegas, S. Cook et al., “Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission,” Infection, Genetics and Evolution, vol. 12, no. 2, pp. 332–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
  140. T. J. Chambers, D. W. McCourt, and C. M. Rice, “Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis,” Virology, vol. 169, no. 1, pp. 100–109, 1989. View at Google Scholar · View at Scopus
  141. J. M. MacKenzie, A. A. Khromykh, M. K. Jones, and E. G. Westaway, “Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A,” Virology, vol. 245, no. 2, pp. 203–215, 1998. View at Publisher · View at Google Scholar · View at Scopus
  142. J. L. Wen, B. C. Hua, J. W. Xiang, H. Huang, and A. A. Khromykh, “Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription,” Journal of Virology, vol. 78, no. 22, pp. 12225–12235, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. W. J. Liu, X. J. Wang, D. C. Clark, M. Lobigs, R. A. Hall, and A. A. Khromykh, “A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice,” Journal of Virology, vol. 80, no. 5, pp. 2396–2404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  144. J. L. Muñoz-Jordán, G. G. Sánchez-Burgos, M. Laurent-Rolle, and A. García-Sastre, “Inhibition of interferon signaling by dengue virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 14333–14338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. W. J. Liu, X. J. Wang, V. V. Mokhonov, P.-Y. Shi, R. Randall, and A. A. Khromykh, “Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins,” Journal of Virology, vol. 79, no. 3, pp. 1934–1942, 2005. View at Publisher · View at Google Scholar · View at Scopus
  146. B. M. Kümmerer and C. M. Rice, “Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles,” Journal of Virology, vol. 76, no. 10, pp. 4773–4784, 2002. View at Publisher · View at Google Scholar · View at Scopus
  147. W. J. Liu, H. B. Chen, and A. A. Khromykh, “Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication,” Journal of Virology, vol. 77, no. 14, pp. 7804–7813, 2003. View at Publisher · View at Google Scholar · View at Scopus
  148. J. Y. Leung, G. P. Pijlman, N. Kondratieva, J. Hyde, J. M. Mackenzie, and A. A. Khromykh, “Role of nonstructural protein NS2A in flavivirus assembly,” Journal of Virology, vol. 82, no. 10, pp. 4731–4741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. K. L. McElroy, K. A. Tsetsarkin, D. L. Vanlandingham, and S. Higgs, “Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3 non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut,” The American Journal of Tropical Medicine and Hygiene, vol. 75, no. 6, pp. 1158–1164, 2006. View at Google Scholar · View at Scopus
  150. K. A. Hanley, L. R. Manlucu, L. E. Gilmore et al., “A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4,” Virology, vol. 312, no. 1, pp. 222–232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  151. E. P. Kelly, B. Puri, W. Sun, and B. Falgout, “Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate,” Vaccine, vol. 28, no. 17, pp. 3030–3037, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. S. Tajima, T. Takasaki, and I. Kurane, “Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B,” Archives of Virology, vol. 156, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. D. Grant, G. K. Tan, M. Qing et al., “A single amino acid in nonstructural protein NS4B Confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis,” Journal of Virology, vol. 85, no. 15, pp. 7775–7787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  154. R. R. Roche, M. Alvarez, M. G. Guzman, L. Morier, and G. Kouri, “Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells,” Journal of Clinical Microbiology, vol. 38, no. 9, pp. 3508–3510, 2000. View at Google Scholar · View at Scopus
  155. W.-K. Wang, S.-R. Lin, C.-M. Lee, C.-C. King, and S.-C. Chang, “Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies,” Journal of Virology, vol. 76, no. 9, pp. 4662–4665, 2002. View at Publisher · View at Google Scholar · View at Scopus
  156. J. Aaskov, K. Buzacott, H. M. Thu, K. Lowry, and E. C. Holmes, “Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes,” Science, vol. 311, no. 5758, pp. 236–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. M. OhAinle, A. Balmaseda, A. R. Macalalad et al., “Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity,” Science Translational Medicine, vol. 3, no. 114, Article ID 114ra128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. J. E. Foster, S. N. Bennett, C. V. F. Carrington, H. Vaughan, and W. O. McMillan, “Phylogeography and molecular evolution of dengue 2 in the Caribbean basin, 1981–2000,” Virology, vol. 324, no. 1, pp. 48–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. W. B. Messer, U. T. Vitarana, K. Sivananthan et al., “Epidemiology of dengue in Sri lanka before and after the emergence of epidemic dengue hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 66, no. 6, pp. 765–773, 2002. View at Google Scholar · View at Scopus
  160. H. M. Thu, K. Lowry, L. Jiang, T. Hlaing, E. C. Holmes, and J. Aaskov, “Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection,” Virology, vol. 336, no. 2, pp. 163–172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  161. L. T. D. Salda, M. D. C. Parquet, R. R. Matias, F. F. Natividad, N. Kobayashi, and K. Morita, “Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 4, pp. 796–802, 2005. View at Google Scholar · View at Scopus
  162. T. T. H. Vu, E. C. Holmes, V. Duong et al., “Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia,” PLoS Neglected Tropical Diseases, vol. 4, no. 7, p. e757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. E. C. Holmes, “RNA virus genomics: a world of possibilities,” Journal of Clinical Investigation, vol. 119, no. 9, pp. 2488–2495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. D. Limonta, V. Capó, G. Torres, A. B. Pérez, and M. G. Guzmán, “Apoptosis in tissues from fatal dengue shock syndrome,” Journal of Clinical Virology, vol. 40, no. 1, pp. 50–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  165. A. Moya, E. C. Holmes, and F. González-Candelas, “The population genetics and evolutionary epidemiology of RNA viruses,” Nature Reviews Microbiology, vol. 2, no. 4, pp. 279–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  166. S. Navas, J. Martín, J. A. Quiroga, I. Castillo, and V. Carreño, “Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients,” Journal of Virology, vol. 72, no. 2, pp. 1640–1646, 1998. View at Google Scholar · View at Scopus
  167. R. Miralles, A. Moya, and S. F. Elena, “Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations,” Journal of General Virology, vol. 80, no. 8, pp. 2051–2059, 1999. View at Google Scholar · View at Scopus
  168. P. Farci, A. Shimoda, A. Coiana et al., “The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies,” Science, vol. 288, no. 5464, pp. 339–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  169. E. C. Holmes, “Patterns of intra- and interhost nonsynonymous variation reveal strong purifying selection in dengue virus,” Journal of Virology, vol. 77, no. 20, pp. 11296–11298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  170. S.-R. Lin, S.-C. Hsieh, Y.-Y. Yueh et al., “Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution,” Journal of Virology, vol. 78, no. 22, pp. 12717–12721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. E. Descloux, V.-M. Cao-Lormeau, C. Roche, and X. De Lamballerie, “Dengue 1 diversity and microevolution, French Polynesia 2001–2006: connection with epidemiology and clinics,” PLoS Neglected Tropical Diseases, vol. 3, no. 8, article e493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. K. T. D. Thai, M. R. Henn, M. C. Zody et al., “High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections,” Journal of Virology, vol. 86, no. 2, pp. 835–843, 2012. View at Publisher · View at Google Scholar · View at Scopus
  173. P. Parameswaran, P. Charlebois, Y. Tellez et al., “Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity,” Journal of Virology, vol. 86, no. 16, pp. 8546–8558, 2012. View at Publisher · View at Google Scholar
  174. R. L. Costa, C. M. Voloch, and C. G. Schrago, “Comparative evolutionary epidemiology of dengue virus serotypes,” Infection, Genetics and Evolution, vol. 12, no. 2, pp. 309–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  175. J. Lourenço and M. Recker, “Viral and epidemiological determinants of the invasion dynamics of Novel Dengue Genotypes,” PLoS Neglected Tropical Diseases, vol. 4, no. 11, article e894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. V. Wittke, T. E. Robb, H. M. Thu et al., “Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period,” Virology, vol. 301, no. 1, pp. 148–156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  177. C. Chevillon and A.-B. Failloux, “Questions on viral population biology to complete dengue puzzle,” Trends in Microbiology, vol. 11, no. 9, pp. 415–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  178. L. Lambrechts, T. Fansiri, A. Pongsiri et al., “Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission,” Journal of Virology, vol. 86, no. 3, pp. 1853–1861, 2012. View at Publisher · View at Google Scholar · View at Scopus
  179. W. H. Bancroft, R. M. Scott, and W. E. Brandt, “Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipients,” The American Journal of Tropical Medicine and Hygiene, vol. 31, no. 6, pp. 1229–1231, 1982. View at Google Scholar · View at Scopus
  180. B. R. Miller, B. J. Beaty, and T. H. G. Aitken, “Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegypti,” The American Journal of Tropical Medicine and Hygiene, vol. 31, no. 6, pp. 1232–1237, 1982. View at Google Scholar · View at Scopus
  181. D. J. Gubler, S. Nalim, and R. Tan, “Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti,” The American Journal of Tropical Medicine and Hygiene, vol. 28, no. 6, pp. 1045–1052, 1979. View at Google Scholar · View at Scopus
  182. P. M. Armstrong and R. Rico-Hesse, “Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus,” Vector Borne Zoonotic Dis, vol. 1, no. 2, pp. 159–168, 2001. View at Google Scholar · View at Scopus
  183. F. L. Soper, “Aedes aegypti and yellow fever,” Bulletin of the World Health Organization, vol. 36, no. 4, pp. 521–527, 1967. View at Google Scholar · View at Scopus
  184. D. J. Gubler, “Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture,” The American Journal of Tropical Medicine and Hygiene, vol. 40, no. 6, pp. 571–578, 1989. View at Google Scholar · View at Scopus
  185. E.-E. Ooi, K.-T. Goh, and D. J. Gubler, “Dengue prevention and 35 years of vector control in Singapore,” Emerging Infectious Diseases, vol. 12, no. 6, pp. 887–893, 2006. View at Google Scholar · View at Scopus
  186. M. G. Guzman, O. Pelaez, G. Kouri et al., “Final characterization of and lessons learned from the dengue 3 epidemic in Cuba, 2001-2002,” Revista Panamericana de Salud Pública, vol. 19, no. 4, pp. 282–289, 2006. View at Google Scholar
  187. M. Bonet, J. M. Spiegel, A. M. Ibarra, G. Kouri, A. Pintre Lic, and A. Yassi, “An integrated ecosystem approach for sustainable prevention and control of dengue in Central Havana,” International Journal of Occupational and Environmental Health, vol. 13, no. 2, pp. 188–194, 2007. View at Google Scholar · View at Scopus
  188. J. A. Bisset, M. M. Rodríguez, Y. Ricardo et al., “Temephos resistance and esterase activity in the mosquito Aedes aegypti in Havana, Cuba increased dramatically between 2006 and 2008,” Medical and Veterinary Entomology, vol. 25, no. 3, pp. 233–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. R. Maciel-de-Freitas, R. Aguiar, R. V. Bruno et al., “Why do we need alternative tools to control mosquito-borne diseases in Latin America?” Memórias do Instituto Oswaldo Cruz, vol. 107, no. 6, pp. 828–829, 2012. View at Google Scholar
  190. R. A. Sá, N. D. D. L. Santos, C. S. B. D. Silva et al., “Larvicidal activity of lectins from Myracrodruon urundeuva on Aedes aegypti,” Comparative Biochemistry and Physiology Part C, vol. 149, no. 3, pp. 300–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  191. P. F. Billingsley, B. Foy, and J. L. Rasgon, “Mosquitocidal vaccines: a neglected addition to malaria and dengue control strategies,” Trends in Parasitology, vol. 24, no. 9, pp. 396–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  192. J. A. Bisset Lazcano, M. C. Marquetti, A. Garcia et al., “Pupal surveillance of Aedes aegypti as a tool for control of the vector in a municipality with low density of La Habana City, Cuba,” Revista Biomédica, vol. 19, pp. 92–103, 2008. View at Google Scholar
  193. T. T. Tuyet Hanh, P. S. Hill, B. H. Kay, and M. Q. Tran, “Development of a framework for evaluating the sustainability of community-based dengue control projects,” The American Journal of Tropical Medicine and Hygiene, vol. 80, no. 2, pp. 312–318, 2009. View at Google Scholar · View at Scopus
  194. S. N. Vu, T. Y. Nguyen, B. H. Kay, G. G. Marten, and J. W. Reid, “Eradication of Aedes aegypti from a village in Vietnam, using copepods and community participation,” The American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, pp. 657–660, 1998. View at Google Scholar · View at Scopus
  195. V. S. Nam, N. T. Yen, T. V. Phong et al., “Elimination of dengue by community programs using Mesocyclops (copepoda) against Aedes aegypti in central Vietnam,” The American Journal of Tropical Medicine and Hygiene, vol. 72, no. 1, pp. 67–73, 2005. View at Google Scholar · View at Scopus
  196. B. Kay and V. S. Nam, “New strategy against Aedes aegypti in Vietnam,” The Lancet, vol. 365, no. 9459, pp. 613–617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  197. L. Sánchez, D. Pérez, L. Alfonso et al., “A community education strategy to promote participation in dengue prevention in Cuba,” Revista Panamericana de Salud Publica, vol. 24, no. 1, pp. 61–69, 2008. View at Google Scholar · View at Scopus
  198. C. J. McMeniman, R. V. Lane, B. N. Cass et al., “Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti,” Science, vol. 323, no. 5910, pp. 141–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  199. P. Lu, G. Bian, X. Pan, and Z. Xi, “Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells,” PLOS Neglected Tropical Diseases, vol. 6, no. 7, Article ID e1754, 2012. View at Google Scholar
  200. T. Walker, P. H. Johnson, L. A. Moreira et al., “The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations,” Nature, vol. 476, no. 7361, pp. 450–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  201. G. Bian, Y. Xu, P. Lu, Y. Xie, and Z. Xi, “The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in Aedes aegypti,” PLoS Pathogens, vol. 6, no. 4, Article ID e1000833, 2010. View at Google Scholar · View at Scopus
  202. L. A. Moreira, I. Iturbe-Ormaetxe, J. A. Jeffery et al., “A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium,” Cell, vol. 139, no. 7, pp. 1268–1278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  203. X. Pan, G. Zhou, J. Wu et al., “Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 1, pp. E23–E31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  204. L. Mousson, K. Zouache, C. Arias-Goeta, V. Raquin, P. Mavingui, and A. B. Failloux, “The native wolbachia symbionts limit transmission of dengue virus in Aedes albopictus,” PLOS Neglected Tropical Diseases, vol. 6, no. 12, Article ID e1989, 2012. View at Google Scholar
  205. P. E. Cook, C. J. McMeniman, and S. L. O'Neill, “Modifying insect population age structure to control vector-borne disease,” Advances in Experimental Medicine and Biology, vol. 627, pp. 126–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  206. N. M. Endersby, A. A. Hoffmann, V. L. White, S. A. Ritchie, P. H. Johnson, and A. R. Weeks, “Changes in the genetic structure of Aedes aegypti (Diptera: Culicidae) populations in Queensland, Australia, across two seasons: implications for potential mosquito releases,” Journal of Medical Entomology, vol. 48, no. 5, pp. 999–1007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  207. N. M. Endersby, A. A. Hoffmann, V. L. White et al., “Genetic structure of Aedes aegypti in Australia and Vietnam revealed by microsatellite and exon primed intron crossing markers suggests feasibility of local control options,” Journal of Medical Entomology, vol. 46, no. 5, pp. 1074–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  208. J. A. L. Jeffery, N. T. Yen, V. S. Nam et al., “Characterizing the Aedes aegypti population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue,” PLoS Neglected Tropical Diseases, vol. 3, no. 11, Article ID e0000552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  209. H. L. Yeap, P. Mee, T. Walker et al., “Dynamics of the “popcorn” Wolbachia infection in outbred Aedes aegypti informs prospects for mosquito vector control,” Genetics, vol. 187, no. 2, pp. 583–595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  210. R. Macey, “Dengue fever breakthrough,” Sydney Morning Herald, 2009, http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html.
  211. N. M. Endersby and A. A. Hoffmann, “Effect of Wolbachia on insecticide susceptibility in lines of Aedes aegypti,” Bulletin of Entomological Research, pp. 1–9, 2012. View at Google Scholar
  212. S. B. Halstead, “Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade,” Reviews of Infectious Diseases, vol. 11, pp. S830–839, 1989. View at Google Scholar · View at Scopus
  213. J. Hombach, M. Jane Cardosa, A. Sabchareon, D. W. Vaughn, and A. D. T. Barrett, “Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005,” Vaccine, vol. 25, no. 21, pp. 4130–4139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  214. S. Swaminathan, G. Batra, and N. Khanna, “Dengue vaccines: state of the art,” Expert Opinion on Therapeutic Patents, vol. 20, no. 6, pp. 819–835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  215. R. Edelman, S. S. Wasserman, S. A. Bodison et al., “Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine,” The American Journal of Tropical Medicine and Hygiene, vol. 69, no. 6, pp. 48–60, 2003. View at Google Scholar · View at Scopus
  216. S. Simasathien, S. J. Thomas, V. Watanaveeradej et al., “Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children,” The American Journal of Tropical Medicine and Hygiene, vol. 78, no. 3, pp. 426–433, 2008. View at Google Scholar · View at Scopus
  217. W. Sun, D. Cunningham, S. S. Wasserman et al., “Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults,” Human Vaccines, vol. 5, no. 1, pp. 33–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  218. A. P. Durbin, S. S. Whitehead, J. McArthur et al., “rDEN4σ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers,” Journal of Infectious Diseases, vol. 191, no. 5, pp. 710–718, 2005. View at Publisher · View at Google Scholar · View at Scopus
  219. A. P. Durbin, J. McArthur, J. A. Marron et al., “The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers,” Human Vaccines, vol. 2, no. 4, pp. 167–173, 2006. View at Google Scholar · View at Scopus
  220. A. P. Durbin, J. H. McArthur, J. A. Marron et al., “rDEN2/4Δ30(ME), a live attenuated chimeric dengue serotype 2 vaccine, is safe and highly immunogenic in healthy dengue-naïve adults,” Human Vaccines, vol. 2, no. 6, pp. 255–260, 2006. View at Google Scholar · View at Scopus
  221. J. H. McArthur, A. P. Durbin, J. A. Marron et al., “Phase I clinical evaluation of rDEN4Δ30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity,” The American Journal of Tropical Medicine and Hygiene, vol. 79, no. 5, pp. 678–684, 2008. View at Google Scholar · View at Scopus
  222. J. E. Blaney Jr., N. S. Sathe, L. Goddard et al., “Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3 untranslated region (3-UTR) or by exchange of the DENV-3 3-UTR with that of DENV-4,” Vaccine, vol. 26, no. 6, pp. 817–828, 2008. View at Publisher · View at Google Scholar · View at Scopus
  223. M. G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guillén, “Domain III of the envelope protein as a dengue vaccine target,” Expert Review of Vaccines, vol. 9, no. 2, pp. 137–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  224. F. Guirakhoo, S. Kitckener, D. Morrison et al., “Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity—effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes,” Human Vaccines, vol. 2, no. 2, pp. 60–67, 2006. View at Google Scholar · View at Scopus
  225. B. Guy, N. Nougarede, S. Begue et al., “Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects,” Vaccine, vol. 26, no. 45, pp. 5712–5721, 2008. View at Publisher · View at Google Scholar · View at Scopus
  226. B. Guy, F. Guirakhoo, V. Barban, S. Higgs, T. P. Monath, and J. Lang, “Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses,” Vaccine, vol. 28, no. 3, pp. 632–649, 2010. View at Publisher · View at Google Scholar · View at Scopus
  227. B. Guy, M. Saville, and J. Lang, “Development of Sanofi Pasteur tetravalent dengue vaccine,” Human Vaccines, vol. 6, no. 9, pp. 696–705, 2010. View at Publisher · View at Google Scholar · View at Scopus
  228. A. Sabchareon, D. Wallace, C. Sirivichayakul et al., “Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial,” The Lancet, vol. 380, no. 9853, pp. 1559–1567, 2012. View at Google Scholar
  229. S. Swaminathan, N. Khanna, B. Herring, and S. Mahalingam, “Dengue vaccine efficacy trial: does interference cause failure?” The Lancet Infectious Diseases, vol. 13, no. 3, pp. 191–192, 2013. View at Google Scholar
  230. M. G. Guzman, A. Alvarez, S. Vazquez et al., “Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002,” International Journal of Infectious Diseases, vol. 16, no. 3, pp. e198–e203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  231. S. B. Halstead, “Dengue vaccine development: a 75% solution?” The Lancet, vol. 380, no. 9853, pp. 1535–1536, 2012. View at Google Scholar
  232. W. M. P. B. Wahala and A. M. de Silva, “The human antibody response to dengue virus infection,” Viruses, vol. 3, no. 12, pp. 2374–2395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  233. J. E. Osorio, C. Y.-H. Huang, R. M. Kinney, and D. T. Stinchcomb, “Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever,” Vaccine, vol. 29, no. 42, pp. 7251–7260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  234. J. E. Osorio, J. N. Brewoo, S. J. Silengo et al., “Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in cynomolgus macaques,” The American Journal of Tropical Medicine and Hygiene, vol. 84, no. 6, pp. 978–987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  235. J. N. Brewoo, R. M. Kinney, T. D. Powell et al., “Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice,” Vaccine, vol. 30, no. 8, pp. 1513–1520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  236. L. Hermida, L. Bernardo, J. Martín et al., “A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates,” Vaccine, vol. 24, no. 16, pp. 3165–3171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  237. L. Bernardo, A. Izquierdo, M. Alvarez et al., “Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates,” Antiviral Research, vol. 80, no. 2, pp. 194–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  238. A. Izquierdo, L. Bernardo, J. Martin et al., “Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus,” Virus Research, vol. 138, no. 1-2, pp. 135–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  239. B. Etemad, G. Batra, R. Raut et al., “An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes,” The American Journal of Tropical Medicine and Hygiene, vol. 79, no. 3, pp. 353–363, 2008. View at Google Scholar · View at Scopus
  240. G. Gao, Q. Wang, Z. Dai et al., “Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes,” Human Gene Therapy, vol. 19, no. 9, pp. 927–936, 2008. View at Publisher · View at Google Scholar · View at Scopus
  241. S. Brandler, M. Lucas-Hourani, A. Moris et al., “Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus,” PLoS Neglected Tropical Diseases, vol. 1, no. 3, article e96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  242. I. Valdés, L. Bernardo, L. Gil et al., “A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice,” Virology, vol. 394, no. 2, pp. 249–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  243. E. Marcos, L. Gil, L. Lazo et al., “Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus,” Archives of Virology, vol. 158, no. 1, pp. 225–230, 2013. View at Google Scholar
  244. L. Lazo, L. Gil, C. Lopez et al., “A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice,” Acta Tropica, vol. 124, no. 2, pp. 107–112, 2012. View at Publisher · View at Google Scholar
  245. L. Gil, L. Bernardo, A. Pavon et al., “Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice,” Journal of General Virology, vol. 93, part 6, pp. 1204–1214, 2012. View at Google Scholar
  246. C.-Y. Chiang, S.-J. Liu, J.-P. Tsai et al., “A novel single-dose dengue subunit vaccine induces memory immune responses,” PLoS ONE, vol. 6, no. 8, Article ID e23319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  247. C. Y. Chiang, M. H. Huang, C. H. Hsieh et al., “Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses,” PLOS Neglected Tropical Diseases, vol. 6, no. 5, Article ID e1645, 2012. View at Publisher · View at Google Scholar
  248. S. B. Halstead, “Controversies in dengue pathogenesis,” Paediatrics and International Child Health, vol. 32, supplement 1, pp. 5–9, 2012. View at Publisher · View at Google Scholar
  249. S. J. Thomas and T. P. Endy, “Critical issues in dengue vaccine development,” Current Opinion in Infectious Diseases, vol. 24, no. 5, pp. 442–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  250. J. D. Brien, S. K. Austin, S. Sukupolvi-Petty et al., “Genotype-specific neutralization and protection by antibodies against dengue virus type 3,” Journal of Virology, vol. 84, no. 20, pp. 10630–10643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  251. M. Bollati, K. Alvarez, R. Assenberg et al., “Structure and functionality in flavivirus NS-proteins: perspectives for drug design,” Antiviral Research, vol. 87, no. 2, pp. 125–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  252. E. A. Gould, T. Solomon, and J. S. Mackenzie, “Does antiviral therapy have a role in the control of Japanese encephalitis?” Antiviral Research, vol. 78, no. 1, pp. 140–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  253. R. M. Kinney, C. Y.-H. Huang, B. C. Rose et al., “Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers,” Journal of Virology, vol. 79, no. 8, pp. 5116–5128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  254. D. A. Stein, C. Y.-H. Huang, S. Silengo et al., “Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 3, pp. 555–565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  255. P. Kumar, H. Wu, J. L. McBride et al., “Transvascular delivery of small interfering RNA to the central nervous system,” Nature, vol. 448, no. 7149, pp. 39–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  256. D. Ray and P.-Y. Shi, “Recent advances in flavivirus antiviral drug discovery and vaccine development,” Recent Patents on Anti-Infective Drug Discovery, vol. 1, no. 1, pp. 45–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  257. S. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi, and T. Yamase, “Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates,” Antiviral Research, vol. 58, no. 3, pp. 265–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  258. L. B. Talarico, C. A. Pujol, R. G. M. Zibetti et al., “The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell,” Antiviral Research, vol. 66, no. 2-3, pp. 103–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  259. L. Ono, W. Wollinger, I. M. Rocco, T. L. M. Coimbra, P. A. J. Gorin, and M.-R. Sierakowski, “In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain),” Antiviral Research, vol. 60, no. 3, pp. 201–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  260. P. Leyssen, A. Van Lommel, C. Drosten, H. Schmitz, E. De Clercq, and J. Neyts, “A novel model for the study of the therapy of flavivirus infections using the Modoc virus,” Virology, vol. 279, no. 1, pp. 27–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
  261. P. Leyssen, J. Balzarini, E. De Clercq, and J. Neyts, “The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase,” Journal of Virology, vol. 79, no. 3, pp. 1943–1947, 2005. View at Publisher · View at Google Scholar · View at Scopus
  262. J. D. Morrey, D. F. Smee, R. W. Sidwell, and C. Tseng, “Identification of active antiviral compounds against a New York isolate of West Nile virus,” Antiviral Research, vol. 55, no. 1, pp. 107–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  263. J. W. Huggins, “Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug,” Reviews of Infectious Diseases, vol. 11, pp. S750–761, 1989. View at Google Scholar · View at Scopus
  264. J. W. Huggins, R. K. Robins, and P. G. Canonico, “Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses,” Antimicrobial Agents and Chemotherapy, vol. 26, no. 4, pp. 476–480, 1984. View at Google Scholar · View at Scopus
  265. J. Neyts, A. Meerbach, P. McKenna, and E. De Clercq, “Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections,” Antiviral Research, vol. 30, no. 2-3, pp. 125–132, 1996. View at Publisher · View at Google Scholar · View at Scopus
  266. F. J. Malinoski, S. E. Hasty, M. A. Ussery, and J. M. Dalrymple, “Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys,” Antiviral Research, vol. 13, no. 3, pp. 139–150, 1990. View at Publisher · View at Google Scholar · View at Scopus
  267. W. C. Koff, R. D. Pratt, J. L. Elm Jr., C. N. Venkateshan, and S. B. Halstead, “Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin,” Antimicrobial Agents and Chemotherapy, vol. 24, no. 1, pp. 134–136, 1983. View at Google Scholar · View at Scopus
  268. P. LaColla and J. P. Sommadossi, “Methods and compositions for treating flaviviruses and pestiviruses,” US6812219, 2004.
  269. M. S. Diamond, M. Zachariah, and E. Harris, “Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA,” Virology, vol. 304, no. 2, pp. 211–221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  270. M. D. Sintchak, M. A. Fleming, O. Futer et al., “Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid,” Cell, vol. 85, no. 6, pp. 921–930, 1996. View at Publisher · View at Google Scholar · View at Scopus
  271. D. P. Stamos and R. S. Bethiel, “Prodrugs of carbamate inhibitors of IMPDH,” US6825224, 2004.
  272. V. Nair, G. Chi, Q. Shu, J. Julander, and D. F. Smee, “A heterocyclic molecule with significant activity against dengue virus,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 5, pp. 1425–1427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  273. X. G. Zhang, P. W. Mason, E. J. Dubovi et al., “Antiviral activity of geneticin against dengue virus,” Antiviral Research, vol. 83, no. 1, pp. 21–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  274. E. Mastrangelo, M. Pezzullo, T. De Burghgraeve et al., “Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 8, pp. 1884–1894, 2012. View at Publisher · View at Google Scholar
  275. S. J. F. Kaptein, T. De Burghgraeve, M. Froeyen et al., “A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 12, pp. 5269–5280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  276. D. Benarroch, M.-P. Egloff, L. Mulard, C. Guerreiro, J.-L. Romette, and B. Canard, “A structural basis for the inhibition of the NS5 dengue virus mRNA 2-O-methyltransferase domain by ribavirin 5-triphosphate,” Journal of Biological Chemistry, vol. 279, no. 34, pp. 35638–35643, 2004. View at Publisher · View at Google Scholar · View at Scopus
  277. J. G. Julander, K. Shafer, D. F. Smee, J. D. Morrey, and Y. Furuta, “Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 1, pp. 202–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  278. S. Cheenpracha, C. Karalai, C. Ponglimanont, S. Subhadhirasakul, and S. Tewtrakul, “Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata,” Bioorganic and Medicinal Chemistry, vol. 14, no. 6, pp. 1710–1714, 2006. View at Publisher · View at Google Scholar · View at Scopus